Skip to main content
VCbacked
Log inGet Started

Abdera Therapeutics

Vancouver, Canada

Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.

$142.0M raised
Apr 2023
Series B
BiotechnologyHealth CareHealth DiagnosticsLife ScienceOncology

Top Investors

Versant VenturesRTW InvestmentsQiming Venture Partners USAViking Global InvestorsAmplitude Venture Capital

Founder Contacts

19,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Abdera Therapeutics

How much funding has Abdera Therapeutics raised?
Abdera Therapeutics has raised $142.0M in total funding. The most recent round was Series B. The last funding was announced in April 2023.
Who are Abdera Therapeutics's investors?
Abdera Therapeutics's investors include Versant Ventures, RTW Investments, Qiming Venture Partners USA, Viking Global Investors, Amplitude Venture Capital.
Where is Abdera Therapeutics headquartered?
Abdera Therapeutics is headquartered in Vancouver, Canada.
What does Abdera Therapeutics do?
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
What stage is Abdera Therapeutics at?
Abdera Therapeutics is at the Series B stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Abdera Therapeutics — Funding & Investors." VCBacked, April 20, 2023, https://www.vcbacked.co/company/abdera-therapeutics. Accessed June 3, 2026.
APA
VCBacked. (2023). Abdera Therapeutics — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/abdera-therapeutics
Wikipedia (cite web)
{{cite web |title=Abdera Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/abdera-therapeutics |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Biotechnology

View all
Virtuoso Surgical
Nashville
Pharvaris
Zug
Odyssey Therapeutics
Boston$213.0M
Tempus
Chicago
Anagram Therapeutics
Boston
Prenetics
Hong Kong